NIDA-MDS-0002

Division
DTMC
HEAL Study
No
Investigator(s)
Thomas F. Newton, M.D.
Title
Assessment of Interactions Between Methamphetamine and Aripiprazole
Short Description
The purpose of this study is to assess the interactions between intravenous methamphetamine and aripiprazole.
Release Date
May 07, 2018
Description

This is a double-blind, placebo-controlled human laboratory clinical pharmacology study to assess potential interactions between intravenous d-methamphetamine infusion and treatment with oral aripiprazole.

Keywords
Aripiprazole
interaction
methamphetamine
phase 1b
stimulant
Assessments
Addiction Research Center Inventory
Beck Depression Inventory
Blood Methamphetamine Level
Brief Substance Craving Scale
Brief Symptom Inventory
ECG Monitoring
Profile of Mood States
Urine Methamphetamine Level
Visual Analog Scales
Vital Signs Monitoring
Accessibility Notice

Please note that the supplementary documents may not be fully Section 508 compliant. Please contact us for assistance.

Study Data
MDS-0002 Data
Study Links
Primary Manuscript
https://www.ncbi.nlm.nih.gov/pubmed/18664303
ClinicalTrials.gov Link
https://clinicaltrials.gov/ct2/show/NCT00089440
Study Documents
Protocol
MDS0002-Protocol.pdf
Dictionary
MDS0002_DD.xlsx
Case Report Form(s)
MDS0002-CRF.pdf
Deidentification Notes
MDS0002-DeidentificationNotes.pdf
Nulled Values
MDS0002-nulled-values.csv
All Documents
MDS0002 - AllDocuments.zip